BRIEF-Perrigo announces FDA final approval for the generic version of Axiron topical solution
March 01, 2017 at 09:02 AM EST
* Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml Source text for Eikon: Further company coverage:
